analogue of natural anthracycline antibiotics containing daunosamineand a 2,6-dideoxy-L-hexose.
Most of the natural anthracycline antibiotics with oligosaccharide side chains, as in the rhodomycin and cinerubin series, contain daunosamine as the sugar directly attached to the anthracyclinone and are of interest as antitumor agents1*. Only in a few cases, daunosamine appears as the non reducing terminal sugar2>3). These compounds also showed high degree of antitumor activity. As part of our program to obtain new anthracycline antibiotics, we decided to synthesize derivatives having daunosamine as the terminal non reducing sugar, in order to compare their biological activity with the natural products, and to be able to make conclusions about the importance of the sequence of sugars in the oligosaccharide side chain.
Synthetic analogs of daunorubicin and doxorubicin have been extensively investigated in our laboratory4 '5) .
Conventional Koenigs-Knorr coupling between daunomycinone or 14-protected adriamycinone and appropriate glycosyl halides is sometimes complicated by low yields and mixtures of anomers. An alternative two-step synthesis6) offers significant advantage. The first step involves mms-alkoxyhalogenation of appropriate glycal precursors with iV-iodosuccinimide (NIS) and daunomycinone (DNM). This glycosidation method has proved useful with sugar aglycons, as demonstrated by Thiem et al?~9), with DNMas shown in earlier work from our group10), and more recently by Danishefsky et a/. 1 1*. The second step employs dehalogenation with tributylstannane (Bu3SnH). This general sequence was used by Umezawa et al. 1 2) to obtain simple 2-deoxy-a-glycosides, and the steric course ofdehalogenation of methyl 2-haloglycosides by Bu3SnDhas been studied in detail in our laboratory13). No traces of disaccharide glycoside 7 were detected. Similar results were observed when the daunosamine derivative lb was coupled to 4-0-acetyl-L-rhamnal15) (8) (Scheme 2) to afford the a-L-(l ->3)-linked disaccharide glycal derivative 9; again treatment with HC1and then with methanol gave only the monosaccharide glycoside 4. These results indicate that the glycal disaccharides 3 and 9 undergo hydrolysis by dry HC1, affording the glycosyl chloride (lb) ofdaunosamine, which then reacts with methanol to give the glycoside 4.
The failure of this conventional glycosidation sequence with the disaccharide glycals 3 and 9 prompted evaluation of the NIS -ROHglycosidation7~9) and Bu3SnHdehalogenation12) as a route to the model methyl glycosides 7 and 12.
Treatment of the (l-»4)-linked glycal 3 (Scheme 1) with NIS and methanol gave a 3.8 : 1 mixture of trans methyl 2-iodo disaccharides 5 and 6. The trans-diaxial isomer 5 was expected to be the major product, based on our previous studies concerning the stereochemistry of NIS -MeOHaddition to the double bond of glycals16' 1 7). This mixture was resolved by column chromatography and the major l ,2-trans-di2Lxia\ product (5) was deiodinated with Bu3SnH to afford the final methyl glycoside disaccharide 7, crystalline in 73% yield.
Similarly, treatment of the (l -»3)-linked glycal 9 (Scheme 2) with NIS -MeOHafforded a mixture of 1,2-trans isomers 10 and ll, here in 3.2 : 1 ratio. The major, trans-di&xial product 10 was likewise treated with Bu3SnHto give the methyl glycoside disaccharide 12, crystalline in 76% yield.
Structural Assignments for Disaccharide Methyl Glycosides Derivatives 5, 6, 7, 10, ll and 12 The products obtained by methoxyiodination of the double bond of 3 (products 5 and 6) and 9 NMRdata on their Bu3SnH reduction-products, compounds 7 and 12, respectively. Both of these 2-deoxyglycosides showed two small coupling constants between H-l and the protons at C-2 (/i,2 eq close to zero and à"/i,2ax= 3-'7, 3.1 Hz for 7 and 12, respectively), indicating that H-l is equatorial. Compounds 7 and 12 also showed large J3A (9.1 -9.3Hz) and J4 5 (9.1 -9.5Hz) values, indicating the trans-diaxial disposition between H-3-H-4 and H-4-H-5 in the favored XC4 (l) conformation. Glycosidation of 9 with Daunomycinone Alkoxyiodination of disaccharide glycal 9 (Scheme 3) with NIS -DNMafforded the trans-diaxia\ addition product 13 as the only observed product, isolated crystalline in 50% yield. Deiodination by Bu3SnH gave the 2-deoxyglycoside 14 in 55% yield. Deprotection of 14 by transesterification with NaOMe and then amide hydrolysis with aqueous NaOH,afforded, after crystallization from HCl -MeOH and ether, the target anthracycline disaccharide glycoside 15 in 32% yield as a crystalline product.
Structural
Assignments for Compounds 13, 14 and 15 The alkoxyiodination product 13 derived from disaccharide glycal 9 showed large JVA. 
Conclusions
This work demonstrates a potentially general and effective synthetic method for producing an oligosaccharide terminated at the reducing end by a glycal, and coupling this in a two-step sequence to a sensitive, highly functionalized alcohol, to produce the corresponding 2-deoxyglycoside of the alcohol and the oligosaccharide. The approach is shown to be particularly effective in synthesis of anthracycline glycosides.
Experime nt al
General Methods Solvents were dried and redistilled just prior to use. Melting points were determined in open glass capillaries by using a Thomas-Hoover apparatus, and are uncorrected. Optical rotations were measured with a Perkin-Elmer Model 141 polarimeter, *H NMRspectra were recorded at 500 MHzwith a Bruker AM-500spectrometer by C. E. Cottrell. The samples were dissolved in the indicated solvent and the chemical shifts (ppm) refer to an internal standard of tetramethylsilane (S = 0.0 ppm). All signal assignments for the disaccharide glycals and methyl glycosides were verified by 13C-1Hcorrelation experiments. Evaporations were performed under vacuum. TLCwas performed on precoated aluminum sheets (0.2 mm) and glass plates (0.25mm) coated with Silica gel 60F254 (E. Merck, Darmstadt); components were detected by spraying the plates with 0. 1 m eerie sulfate in 2 m sulfuric acid, with subsequent heating. Column chromatography was performed with Silica gel 60 (230~400 mesh, E. Merck, Darmstadt). High resolution FABmass spectra were recorded in a Kratos MS-30apparatus by Mr. C. R. Weisenberger. Elemental analysis were determined by Atlantic Microlab (Atlanta, GA).
l -enitol14) (la) (1.0 g, 3.7 mmol) was dissolved in dry benzene (100ml) and the solution evaporated to half its volume. HC1gas was then bubbled through the magnetically stirred solution for 10 minutes at 5°C. After 5 minutes at room temperature, the solvent was evaporated. The residue was redissolved in dry CH2C12, the solution evaporated, and the residue redissolved again, affording a solution of the glycosyl chloride lb in dry CH2C12.
At the same time, HgO (2.31 g, 10.7mmol), HgBr2 (1.48g, 4.1 mmol) and powdered 4A molecular sieves (3.63 g) were mixed in dry CH2C12 (70 ml) and stirred magnetically for 1 hour at room temperature. To this mixture were succesively added a solution of 3-0-acetyl-t-rhamnal15) (2, 1.32 g, 7.6mmol) in dry CH2C12 (10ml) and then the solution of glycosyl chloride lb. The mixture was magnetically stirred at room temperature with TLC monitoring (2 : 1 hexane-EtOAc). After 2 hours the mixture was filtered through Celite and the filtrate was successively washed with 30% aqueous KI, twice with water, and then dried (Na2SO4) and evaporated. The resultant syrup was resolved by column chromatography (5 : 1 hexane-EtOAc) to afford the disaccharide derivative 3 as a solid (640mg, 39%). NOV. 1993
The same procedure was used as for compound 3, except that 4-0-acetyl-L-rhamnal15) (8) was used instead of its 3-0-acetyl isomer 2. A solid was obtained which was crystallized from Et2O-hexane to afford pure 9 (820mg, 50%); mp 184-185°C; [a] Attempted Conversion of Disaccharide Glycal Derivatives 3 and 9 into Methyl 2-Deoxyglycosides by Direct Halogenation-glycosidation 4-0-(4-O-Acetyl-2, 3 ,6-trideoxy-3-trifluoroacetamidd ro-2,6-dideoxy-L-0rafo>20-hex-l-enitol (3) (0.162 g, 0.37 mmol) was dissolved in dry benzene (10 ml) and the solution evaporated to half its volume. HC1gas was then bubbled through the magnetically stirred solution for 10 minutes at 5°C. After 5 minutes at room temperature, the solvent was evaporated. The residue was redissolved in dry CH2C12, the solution evaporated, and the residue redissolved again. At the same time, HgO (0.23 g, 1.07mmol), HgBr2 (0.15g, 0.41 mmol) and powdered 4A molecular sieves (0.36 g) were mixed in dry CH2C12 (7ml) and stirred magnetically for 1 hour at room temperature. To this mixture were succesively added dry MeOH(30/xl, 0.76mmol) and then the previously prepared solution. The mixture was magnetically stirred at room temperature with TLCmonitoring (2: 1 hexane -EtOAc). After 2 hours the mixture was filtered through Celite and the filtrate was successively washed with 30% aqueous KI, twice with water, and then dried (Na2SO4) and evaporated. The resultant syrup (~30mg) showed by TLC, one major product. Purification by a small column chromatography 
The procedure just described was applied with the glycal derivative 9. Column chromatographic purification (5 : 1 hexane -EtOAc) afforded two fractions. The first fraction was obtained as a solid (176 mg, 52%) that crystallized from EtOHand was characterized as the a-L-manno isomer 10; mp 218~220°C; To a solution of the oc-L-manno derivative 5 (100mg, 0.17mmol) in dry benzene (l ml) was added Bu3SnH (50/il, 0.2mmol) and a few mg of azobis (isobutyronitrile) (AIBN) in an inert atmosphere and the mixture was heated at 60°C. The reaction was complete after 2 hours (TLC). The mixture was diluted with CH3CNand washed three times with hexane1 9). The solution was evaporated to a syrup that crystallized from EtOH-hexane to afford pure 7 (58mg, 73%); mp 115~117°C; [a] 
The conditions just described were applied to with the a-L-manno derivative 10. Similar processing gave a solid that crystallized from EtOH to afford pure 12 (60mg, 76%); mp 248~250°C; [a] 
To a solution of glycal derivative 9 (0.50g, L14mmol) and daunomycinone (0.44g, 1.10mmol) in dry CH3CN(8.7ml) and dry THF (3.6ml), was added NIS (0.37 g, 1.64mmol) and the mixture was stirred magnetically at room temperature with TLCmonitoring (3 : 1 toluene -acetone). Somedaunomycinone still remained unreacted after 12 hours, and more 9 (0.25 g, 0.57mmol) and NIS (0.19 g, 0.82mmol) were added. After a further 2 hours the reaction was complete and the solution was diluted with CH2C12(50 ml). The resulting solution was washed with a 10% aqueous Na2S2O3 (2 x 30ml) and water (2 x 30ml), dried (Na2SO4), and evaporated to afford a red solid which was purified by column chromatography (50g of silica gel, 8 : 1 toluene -acetone). The chromatographically major pure fraction was isolated as a red solid which crystallized from acetone-hexane to yield pure 13 (53mg, 50%); mp 170~172°C; [a] To a solution of 13 (0.200g, 0.21 mmol) in dry benzene (6ml), were added Bu3SnH (0.2ml, 0.8mmol) and a few mg of AIBNin an inert atmosphere and the mixture was stirred magnetically at 45°C with TLC monitoring (6 : 1 CHC13 -acetone). After 48 hours the reaction was terminated by evaporation,
